From

Institution

Field

Type

Journal / venue: HemaSphere ×

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers 116

Sort: Cited Newest Oldest Fwci Patents ⇩ CSV

The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders
2021 HemaSphere article Medicine Blood Coagulation and Thrombosis Mechanisms Open access

Sabine Eichinger, Pierre‐Emmanuel Morange, Marco Cattaneo, Mathilde Frétigny, Antoine Rauch, Astrid van Hylckama Vlieg, +8 more

5

citations
Immune‐based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
2020 HemaSphere article Medicine Cancer Immunotherapy and Biomarkers Open access

Hermann Einsele, Javier Briones, Fabio Ciceri, Irene García‐Cadenas, Fred Falkenburg, Natacha Bolaños, +10 more

5

citations
Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients
2021 HemaSphere article Medicine Chronic Myeloid Leukemia Treatments Open access

4

citations
P1023: AVAPRITINIB IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM): EFFICACY AND SAFETY ANALYSES FROM THE PHASE 2 PATHFINDER STUDY WITH 2-YEAR FOLLOW-UP
2023 HemaSphere article Immunology and Microbiology Mast cells and histamine Open access

Jason R. Gotlib, Andreas Reiter, Deepti H. Radia, Michael W. Deininger, Tracy I. George, Jens Panse, +16 more

4

citations
Causes of death among patients diagnosed with chronic lymphocytic leukemia: A population‐based study in the Netherlands, 1996–2020
2024 HemaSphere article Medicine Chronic Lymphocytic Leukemia Research Open access

Lina van der Straten, Mark‐David Levin, Manette A. W. Dinnessen, Otto J. Visser, Eduardus F. M. Posthuma, Jeanette K. Doorduijn, +3 more

4

citations
Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B‐ALL, or T‐ALL
2025 HemaSphere article Medicine Acute Myeloid Leukemia Research Open access

Roger Mulet‐Lazaro, Anikó Sijs‐Szabó, Remco Michiel Hoogenboezem, Stanley van Herk, Carla Exalto, Jasper E. Koenders, +12 more

4

citations
P892: ANALYSIS OF INFECTIONS AND PARAMETERS OF HUMORAL IMMUNITY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH TALQUETAMAB (TAL) MONOTHERAPY IN MONUMENTAL-1
2023 HemaSphere article Medicine Multiple Myeloma Research and Treatments Open access

Leo Rasche, Carolina Schinke, Ajai Chari, Brea C. Lipe, Noa Lavi, Paula Rodríguez‐Otero, +13 more

4

citations
P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION
2023 HemaSphere article Medicine Chronic Lymphocytic Leukemia Research Open access

Núria Martínez‐Cibrián, Sergi Betriu, Valentín Ortiz‐Maldonado, Daniel Esteban, Natalia Tovar, Ana Triguero Moreno, +7 more

4

citations
The EHA Research Roadmap: Transfusion Medicine
2022 HemaSphere article Medicine Blood transfusion and management Open access

Srini V. Kaveri, Jagadeesh Bayry, Miloš Bohoněk, Andreas S. Buser, Jean‐Daniel Tissot, Ashley Mark Toye, +2 more

4

citations
Wnt‐dependent spatiotemporal reprogramming of bone marrow niches drives fibrosis
2026 HemaSphere article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

Bella Banjanin, James Shiniti Nagai, YeVin Mun, Stijn N. R. Fuchs, Inge Snoeren, Joachim Boers, +28 more

3

citations
Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies
2022 HemaSphere article Medicine Acute Myeloid Leukemia Research Open access

Martin Kirschner, Benjamin Rolles, Martina Margrit Crysandt, Christoph Röllig, Friedrich Stölzel, Michael Krämer, +13 more

3

citations
S125: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY (“3 + 7”) FOLLOWED BY ALLOGRAFTING (HSCT) IN AML PATIENTS ≥60 YEARS: A RANDOMIZED PHASE III STUDY OF THE EORTC LEUKEMIA GROUP, GIMEMA, CELG, AND GMDS-SG
2022 HemaSphere article Medicine Acute Myeloid Leukemia Research Open access

M Lübbert, P. W. Wijermans, Michal Kiciński, Sylvain Chantepie, Walter J. F. M. van der Velden, Richard Noppeney, +26 more

3

citations
P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FROM THE GMMG-HD7 TRIAL
2022 HemaSphere article Medicine Multiple Myeloma Research and Treatments Open access

E. K. Mai, Uta Bertsch, R. Fenk, Diana Tichy, Britta Besemer, Jan Dürig, +27 more

3

citations
P774: SUBSTANTIAL INCREASES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE WITH ORAL IPTACOPAN MONOTHERAPY CONFIRMS CONTROL OF HEMOLYSIS IN COMPLEMENT INHIBITOR-NAÏVE PNH PATIENTS
2023 HemaSphere article Immunology and Microbiology Complement system in diseases Open access

Régis Peffault de Latour, Bing Han, Jaroslaw Pawel Maciejewski, Yutaka Ueda, Rong Fu, Li Zhang, +15 more

3

citations
Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT
2023 HemaSphere article Medicine Multiple and Secondary Primary Cancers Open access

Marie Robin, Liesbeth C. de Wreede, Thomas A. Schroeder, Friedrich Stölzel, Nicolaus Kröger, Linda Köster, +18 more

3

citations
Peripheral T‐ and natural killer‐cell lymphomas: ESMO‐EHA Clinical Practice Guideline for diagnosis, treatment, and follow‐up
2025 HemaSphere article Medicine Lymphoma Diagnosis and Treatment Open access

Francesco d’Amore, Massimo Federico, Laurence de Leval, Fredrik Ellin, Olivier Hermine, Won Seog Kim, +6 more

3

citations
S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
2023 HemaSphere article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

Hélène F.E. Gleitz, Inge Snoeren, Stijn N. R. Fuchs, James Shiniti Nagai, Aurélien J. F. Dugourd, Charlotte Boys, +10 more

2

citations
P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA
2022 HemaSphere article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

Frank Stegelmann, Ekaterina Jahn, Steffen Koschmieder, Florian Heinrich Heidel, Andreas Hochhaus, H. Hebart, +18 more

2

citations
Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia
2023 HemaSphere article Medicine Hematopoietic Stem Cell Transplantation Open access

Margherita Vieri, Benjamin Rolles, Maria Crocioni, Mirle Schemionek, Susanne Isfort, Jens Panse, +2 more

2

citations
P831: PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH CROVALIMAB: RESULTS FROM THE COMPOSER TRIAL
2022 HemaSphere article Immunology and Microbiology Complement system in diseases Open access

Alexander Röth, Jens Panse, B. Gentile, Muriel Buri, H. Patel, Zsolt Nagy

2

citations
PB1972: ASC4START: A PHASE IIIB, OPEN-LABEL, RANDOMIZED STUDY OF ASCIMINIB VERSUS NILOTINIB IN PATIENTS WITH NEWLY DIAGNOSED PH+ CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
2023 HemaSphere article Medicine Chronic Myeloid Leukemia Treatments Open access

Andreas Hochhaus, Susanne Saußele, François‐Xavier Mahon, Virginia Pilipovic, Yifan Zhang, Peter Schuld, +1 more

2

citations
S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
2023 HemaSphere article Medicine Acute Myeloid Leukemia Research Open access

Marius Bill, Leo Ruhnke, Sven Zukunft, Silvia Schäfer, Jan‐Niklas Eckardt, Sebastian Stasik, +42 more

2

citations
S182: ORAL IPTACOPAN MONOTHERAPY INCREASES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE VIA CONTROL OF INTRA- AND EXTRAVASCULAR HEMOLYSIS IN ANTI-C5-TREATED PNH PATIENTS WITH ANEMIA
2023 HemaSphere article Immunology and Microbiology Complement system in diseases Open access

Antonio Maria Risitano, Alexander Röth, Austin Gladston Kulasekararaj, Phillip Scheinberg, Yutaka Ueda, Eros Di Bona, +28 more

2

citations
P1017: REDUCTIONS IN INDOLENT SYSTEMIC MASTOCYTOSIS BIOMARKER BURDEN WITH AVAPRITINIB IN THE REGISTRATIONAL, DOUBLE-BLIND PLACEBO-CONTROLLED PIONEER TRIAL
2023 HemaSphere article Immunology and Microbiology Mast cells and histamine Open access

Jason R. Gotlib, Mariana Castells, Hanneke Oude Elberink, Frank Siebenhaar, Karin Hartmann, Sigurd Broesby‐Olsen, +34 more

2

citations
Operational burden and fragmented implementation in CAR T‐cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee
2025 HemaSphere article Medicine CAR-T cell therapy research Open access

Nick van Sinderen, Julie Dolva, Caterina Riillo, Raquel Espada, Christof Scheid, Suzanne van Dorp, +16 more

2

citations